RADIOHYBRID

Owners

Goods & Services

Medical clinic services; Positron Emission Tomography (PET) imaging services; medical imaging services; medical analysis for the diagnosis and treatment of persons; medical consultations

Chemicals for use in scientific research, other than for medical or veterinary purposes; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracer chemicals for scientific and laboratory use; radioactive elements for scientific purposes; diagnostic scanning agents for in-vivo use other than medical purposes; chemicals for use in molecular imaging for scientific or research use

Scientific and technological services, namely, research and design in the field of industrial analysis; industrial analysis and research services in the field of radiopharmaceuticals; design and development of computer hardware and software; product design and development in the field of Positron Emission Tomography (PET) imaging and radionuclide therapy; medical and scientific research in the field of disease diagnosis and treatment; scientific and medical research in the field of molecular imaging; development of molecular imaging products; development of radionuclide therapy products; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services; medical and pharmacological research services; scientific research consulting in the field of medical imaging; Medical laboratory services

Medical, pharmaceutical and veterinary preparations for diagnosis, monitoring and treatment of cancer; sanitary preparations for medical use; diagnostic preparations for medical purposes; medical preparations in the nature of biometallic compounds for consumption or injection for use in medical imaging; contrast agents for use in medical imaging; amino acids for medical purposes; radioactive substances for medical purposes; reagents for medical use; Positron Emission Tomography (PET) tracer chemicals for medical use; Positron Emission Tomography (PET) tracer chemicals prepared for ingestion or injection into humans and animals for medical purposes; diagnostic chemicals for medical purposes; Therapeutic pharmaceutical for the treatment of cancer; reagents for medical purposes; diagnostic scanning agents for medical use; pharmaceutical preparations, namely, radiotherapeutic preparations and radio diagnostic preparations; Diagnostic medical preparations for use in molecular imaging; pharmaceutical preparations, namely, radiotherapeutic preparations and radiodiagnostic preparations; pharmaceutical preparations for the treatment of cancer; diagnostic radiopharmaceutical preparations; radiopharmaceutical products, namely, radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Radiopharmaceuticals used in the field of nuclear medicine, intended for medical imaging and therapy; Pharmaceutical preparations, namely, alpha- and beta-emitting radionuclides for use in radionuclide therapy; synthetic amino acids for medical purposes, namely, use in Positron Emission Tomography (PET) imaging and radionuclide therapy; reagents for medical use, namely, use in Positron Emission Tomography (PET) imaging and radionuclide therapy